7189796
MilliporeSigma™ Supelco™ Discovery™ BIO Wide Pore C18 HPLC Column, 5 μm Particle Size
The Discovery™ BIO Wide Pore C18 column has the ability to analyze peptides without TFA in the mobile phase, thereby increasing the LC-MS signal.
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Particle Size
5 μm
Surface Area
100 m2/g
Product Line
Discovery
Endcapped
Yes
Technique
Wide Pore HPLC
Pore Size
300 Å
Stationary Phase
C18 (octadecyl)
Matrix
C18 (octadecyl) Phase/silica particle platform
Phase
Reversed Phase
Related Products
Description
- Peptide maps generated by RP-HPLC provide valuable information about protein structure, stability, and purity
- To be effective, the RP-HPLC column must be able to resolve a high percentage of the peptides in the sample
- The more peptides, the better the information
- Discovery™ BIO Wide Pore C18 gives unsurpassed RP-HPLC resolution of peptide maps from enzymatic digests
- The improvements in silica and bonded-phase chemistry that have been incorporated into the Discovery™ BIO Wide Pore line improve resolution by increasing efficiency and reducing the peak tailing
- An added benefit to this is the ability to analyze peptides without TFA in the mobile phase, thereby increasing the LC-MS signal.
Compare Similar Items
Show Difference
Particle Size: 5 μm
Surface Area: 100 m2/g
Product Line: Discovery
Endcapped: Yes
Technique: Wide Pore HPLC
Pore Size: 300 Å
Stationary Phase: C18 (octadecyl)
Matrix: C18 (octadecyl) Phase/silica particle platform
Phase: Reversed Phase
Particle Size:
5 μm
Surface Area:
100 m2/g
Product Line:
Discovery
Endcapped:
Yes
Technique:
Wide Pore HPLC
Pore Size:
300 Å
Stationary Phase:
C18 (octadecyl)
Matrix:
C18 (octadecyl) Phase/silica particle platform
Phase:
Reversed Phase
Particle Size: 5 μm
Surface Area: __
Product Line: Astec CHIROBIOTIC
Endcapped: __
Technique: Chiral HPLC
Pore Size: 100 Å
Stationary Phase: Ristocetin A Glycopeptide
Matrix: Ristocetin A Glycopeptide Phase/High-Purity Silica Gel Particle Platform
Phase: Chiral
Particle Size:
5 μm
Surface Area:
__
Product Line:
Astec CHIROBIOTIC
Endcapped:
__
Technique:
Chiral HPLC
Pore Size:
100 Å
Stationary Phase:
Ristocetin A Glycopeptide
Matrix:
Ristocetin A Glycopeptide Phase/High-Purity Silica Gel Particle Platform
Phase:
Chiral
Particle Size: 5 μm
Surface Area: __
Product Line: Astec
Endcapped: __
Technique: __
Pore Size: __
Stationary Phase: __
Matrix: __
Phase: Chiral
Particle Size:
5 μm
Surface Area:
__
Product Line:
Astec
Endcapped:
__
Technique:
__
Pore Size:
__
Stationary Phase:
__
Matrix:
__
Phase:
Chiral
Particle Size: 2.7 μm
Surface Area: __
Product Line: Ascentis
Endcapped: __
Technique: __
Pore Size: 160 Å
Stationary Phase: __
Matrix: __
Phase: Reversed Phase
Particle Size:
2.7 μm
Surface Area:
__
Product Line:
Ascentis
Endcapped:
__
Technique:
__
Pore Size:
160 Å
Stationary Phase:
__
Matrix:
__
Phase:
Reversed Phase